Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Dopamine D3 receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Alpha-1a adrenergic receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Dopamine D1 receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Dopamine D2 receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Serotonin 1a (5-HT1a) receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Alpha-2a adrenergic receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | phenylalanine-4-hydroxylase,phenylalanine-4-hydroxylase, putative | 0.034 | 0.4907 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | phosphoribosylamine--glycine ligase | 0.0305 | 0.4309 | 1 |
Toxoplasma gondii | aromatic amino acid hydrolase AAH2 | 0.0375 | 0.5513 | 1 |
Mycobacterium ulcerans | phosphoribosylamine--glycine ligase | 0.0305 | 0.4309 | 1 |
Echinococcus multilocularis | serotonin receptor | 0.018 | 0.2163 | 0.1245 |
Brugia malayi | Biopterin-dependent aromatic amino acid hydroxylase family protein | 0.0115 | 0.1048 | 0.5 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.018 | 0.2163 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.2163 | 1 |
Mycobacterium tuberculosis | Probable phosphoribosylformylglycinamidine CYCLO-ligase PurM (AIRS) (phosphoribosyl-aminoimidazole synthetase) (air synthase) | 0.0067 | 0.0235 | 0.5 |
Mycobacterium leprae | PROBABLE PHOSPHORIBOSYLAMINE--GLYCINE LIGASE PURD (GARS) (GLYCINAMIDE RIBONUCLEOTIDE SYNTHETASE) (PHOSPHORIBOSYLGLYCINAMIDE SYNT | 0.0305 | 0.4309 | 1 |
Toxoplasma gondii | aromatic amino acid hydrolase AAH1 | 0.034 | 0.4907 | 0.8383 |
Onchocerca volvulus | 0.0067 | 0.0235 | 1 | |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.018 | 0.2163 | 0.1245 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.2163 | 1 |
Echinococcus multilocularis | serotonin receptor | 0.018 | 0.2163 | 0.1245 |
Echinococcus multilocularis | folate receptor beta | 0.0636 | 1 | 1 |
Toxoplasma gondii | phenylalanine-4-hydroxylase | 0.0375 | 0.5513 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 0.87 nM | Binding affinity for rat striatum Dopamine receptor D3 (sf9 cells) by [3H]-7-OH-DPAT displacement. | ChEMBL. | 12930145 |
Ki (binding) | = 0.92 nM | Binding affinity for rat striatum Dopamine receptor D3 (sf9 cells) by [3H]-7-OH-DPAT displacement. | ChEMBL. | 12930145 |
Ki (binding) | = 4.9 nM | Binding affinity for rat hippocampus 5-hydroxytryptamine 1A receptor by inhibition of [3H]-8-OH-DPAT binding | ChEMBL. | 12930145 |
Ki (binding) | = 33 nM | Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]-prazosin binding | ChEMBL. | 12930145 |
Ki (binding) | = 45 nM | Binding affinity for rat striatum Dopamine receptor D2 by [3H]-spiperone displacement. | ChEMBL. | 12930145 |
Ki (binding) | = 60 nM | Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]-prazosin binding | ChEMBL. | 12930145 |
Ki (binding) | = 61 nM | Binding affinity for rat striatum Dopamine receptor D2 by [3H]-spiperone displacement. | ChEMBL. | 12930145 |
Ki (binding) | = 83 nM | Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding | ChEMBL. | 12930145 |
Ki (binding) | = 84 nM | Binding affinity for rat hippocampus 5-hydroxytryptamine 1A receptor by inhibition of [3H]-8-OH-DPAT binding | ChEMBL. | 12930145 |
Ki (binding) | = 89 nM | Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding | ChEMBL. | 12930145 |
Ki (binding) | = 1567 nM | Binding affinity for rat striatum dopamine Dopamine receptor D1 by [3H]-SCH- -2339 displacement. | ChEMBL. | 12930145 |
Ki (binding) | = 3000 nM | Binding affinity for rat striatum dopamine Dopamine receptor D1 by [3H]-SCH- -2339 displacement. | ChEMBL. | 12930145 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.